Showing results (81-90 of 117) with videos related to
Sort By:
Pageof 12
Frontiers in Immunology|May 15, 2023
Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndromeLimor Rubin, Aviv Talmon, Yaarit Ribak, et al.The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Dupilumab for cancer-associated refractory pruritusAviv Talmon, Shlomo Elias, Limor Rubin, et al.The Israel Medical Association Journal : IMAJ|January 14, 2020
A Novel Tool for Nasal Polyp Investigation: An Ex vivo Organ Culture SystemOphir Ilan, Yuval Tal, Alon Y Hershko, et al.BMC Immunology|April 8, 2025
Dual biological treatments in immune-mediated disorders: a single center experienceOded Shamriz, Elchanan Parnasa, Limor Rubin, et al.Respiratory Medicine|May 27, 2026
Acute COPD Exacerbation and Long-Term Cardiopulmonary Outcomes: Real-World EXACOS-CP Evidence Study in IsraelSamah Hayek, Uri Gottlieb, Nir Treves, et al.International Journal of Molecular Sciences|June 2, 2021
The Prominin-1-Derived Peptide Improves Cardiac Function Following IschemiaAvner Adini, Irit Adini, Etty Grad, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 25, 2018
Omalizumab for the Treatment of Solar Urticaria: Case Series and Systematic Review of the LiteratureIgor Snast, Noa Kremer, Moshe Lapidoth, et al.Journal for Immunotherapy of Cancer|October 12, 2024
Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse eventsLimor Rubin, Aviv Talmon, Yaarit Ribak, et al.Photodermatology, Photoimmunology & Photomedicine|March 19, 2021
Isolated solar angioedema: A systematic review of the literatureAnna Aronovich, Igor Snast, Moshe Lapidoth, et al.The Israel Medical Association Journal : IMAJ|May 1, 2017
Anti-BLyS Treatment of 36 Israeli Systemic Lupus Erythematosus PatientsZev Sthoeger, Margalit Lorber, Yuval Tal, et al.Pageof 12